Showing 37,861 - 37,880 results of 43,776 for search '(( 50 ((ms decrease) OR (a decrease)) ) OR ( 5 ((nn decrease) OR (mean decrease)) ))', query time: 1.05s Refine Results
  1. 37861
  2. 37862

    Can carcinoembryonic antigen replace computed tomography in response evaluation of metastatic colorectal cancer? by Kethe Hermunen (4813167)

    Published 2018
    “…Secondarily, increasing CEA was able to identify all PD patients (sensitivity (Se) = 1.0) and in 50–74% of the patients increasing CEA provided a lead time to PD on upcoming CT. …”
  3. 37863

    Ngn2 and NeuroD1 mark the initiation and end of amplification of hippocampal DG granule neuroblasts, respectively. by Laurent Roybon (266715)

    Published 2009
    “…Scale bars: 100 µm (B1, C1 and C2), 50 µm (A1, D1, E1, F1, G1, H1, I1, K and L1), 25 µm (A2, B2, and F2), 10 µm (L2), 5 µm (C3, E2, G2, H2 and I2).…”
  4. 37864

    Effects of static defects and nucleosome rate constant variability on RNAPII density profiles. by Robert C. Mines (12072784)

    Published 2022
    “…GC content heterogeneity is introduced via Eqs <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1009811#pcbi.1009811.e100" target="_blank">49</a> and 50. …”
  5. 37865

    Genome-wide characterization of LTF-responsive viral TSRs. by Ming Li (91180)

    Published 2021
    “…LTF-activated TSRs (orange dots) represent TSRs decreasing in strength by more than 50% because of dTag treatment (LTF-activated TSRs). …”
  6. 37866

    Image 4_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

    Published 2025
    “…The most common AEs in the PC group were blood toxicity related AEs (anemia, neutrophil count decreased, etc).</p>Conclusion<p>The PC therapy continues to provide a substantial survival benefit for patients with stage IIIb-IV NSCLC. …”
  7. 37867

    DataSheet_1_The presence of silver nanoparticles reduces demand for dissolved phosphorus to the benefit of biological nitrogen fixation in the coastal eastern Mediterranean Sea.pdf by Andrew P. Rees (8756361)

    Published 2022
    “…Three mesocosms were left unamended at ambient light and temperature; three were manipulated with 50 ng AgNPs L<sup>-1</sup>d<sup>-1</sup> and three were amended with 50 ng Ag<sup>+</sup> L<sup>-1</sup>d<sup>-1</sup>. …”
  8. 37868

    Table 1_The germinal center-tertiary lymphoid structure after neoadjuvant chemo-immunotherapy for locally advanced lung squamous cell carcinoma can predict the disease progression.... by Lili Jiang (65114)

    Published 2025
    “…</p>Methods<p>The NACT-IO group (72 patients), NACT group (50 patients), UT group (50 patients, un-neoadjuvant therapy) were included. …”
  9. 37869

    Data_Sheet_1_Altered topological properties of functional brain networks in patients with first episode, late-life depression before and after antidepressant treatment.docx by Chaomeng Liu (14721880)

    Published 2023
    “…Objectives<p>To preliminarily explore the functional activity and information integration of the brains under resting state based on graph theory in patients with first-episode, late-life depression (LLD) before and after antidepressant treatment.</p>Methods<p>A total of 50 patients with first-episode LLD and 40 non-depressed controls (NCs) were recruited for the present research. …”
  10. 37870

    Image 5_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

    Published 2025
    “…The most common AEs in the PC group were blood toxicity related AEs (anemia, neutrophil count decreased, etc).</p>Conclusion<p>The PC therapy continues to provide a substantial survival benefit for patients with stage IIIb-IV NSCLC. …”
  11. 37871
  12. 37872
  13. 37873
  14. 37874

    Table 4_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

    Published 2025
    “…The most common AEs in the PC group were blood toxicity related AEs (anemia, neutrophil count decreased, etc).</p>Conclusion<p>The PC therapy continues to provide a substantial survival benefit for patients with stage IIIb-IV NSCLC. …”
  15. 37875

    The Red Imported Fire Ant (<i>Solenopsis invicta</i> Buren) Kept Y not F: Predicted sNPY Endogenous Ligands Deorphanize the Short NPF (sNPF) Receptor by Prati Bajracharya (643415)

    Published 2014
    “…Two <i>S. invicta</i> sNPFs differing at their N-terminus were synthesized that equally activated the sNPFR, SLRSALAAGHLRYa (EC<sub>50</sub> = 3.2 nM) and SALAAGHLRYa (EC<sub>50</sub> = 8.6 nM). …”
  16. 37876
  17. 37877
  18. 37878

    Image 1_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

    Published 2025
    “…The most common AEs in the PC group were blood toxicity related AEs (anemia, neutrophil count decreased, etc).</p>Conclusion<p>The PC therapy continues to provide a substantial survival benefit for patients with stage IIIb-IV NSCLC. …”
  19. 37879

    Image 8_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

    Published 2025
    “…The most common AEs in the PC group were blood toxicity related AEs (anemia, neutrophil count decreased, etc).</p>Conclusion<p>The PC therapy continues to provide a substantial survival benefit for patients with stage IIIb-IV NSCLC. …”
  20. 37880

    Image 2_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

    Published 2025
    “…The most common AEs in the PC group were blood toxicity related AEs (anemia, neutrophil count decreased, etc).</p>Conclusion<p>The PC therapy continues to provide a substantial survival benefit for patients with stage IIIb-IV NSCLC. …”